For patients at high risk for fracture due to osteoporosis
FORTEO (teriparatide [rDNA origin] injection) can help reduce your risk of having another fracture*
FORTEO is a prescription medication used in both men and postmenopausal women with osteoporosis who are at high risk for having broken bones, or fractures. FORTEO is used in both men and women with osteoporosis due to use of glucocorticoid medicines, such as prednisone, for several months, who are at high risk for having broken bones, or fractures. FORTEO can be used by people who have had a fracture related to osteoporosis, or who have several risk factors for fracture, or who cannot use other osteoporosis treatments.
*Only proven in postmenopausal women with osteoporosis. All women took calcium and vitamin D daily.
Lower your monthly cost to $4 with the FORTEO co-pay card†
†For eligible patients. See Rules and Restrictions for eligibility requirements.
Start managing your osteoporosis with FORTEO
Consult your healthcare provider to determine if FORTEO is right for you.
ǂFDA approval in 2002
§Cumulative worldwide exposure through 31 August 2017 across all approved indications.
Join FORTEO Connect™ for free support throughout the full course of treatmentǁ
Joining FORTEO Connect™ provides access to a team of professionals committed to helping you get off to a good start and supporting you every step of the way. FREE support includes:
- FORTEO information and injection training
- Ongoing FORTEO support
- Insurance investigation
ǁYou should not take FORTEO for more than 2 years over your lifetime.